These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28570801)

  • 1. Lurasidone-Induced Rabbit Syndrome: A Case Report.
    Reichenberg JL; Ridout KK; Rickler KC
    J Clin Psychiatry; 2017 May; 78(5):e553. PubMed ID: 28570801
    [No Abstract]   [Full Text] [Related]  

  • 2. Lurasidone-Induced Mania.
    Ward HB; Almeida M
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31298818
    [No Abstract]   [Full Text] [Related]  

  • 3. Lurasidone-Induced Dystonia.
    Tibrewal P; Cheng R; Bastiampillai T; Dhillon R; Okungu A; Campbell J
    Prim Care Companion CNS Disord; 2017 Jun; 19(3):. PubMed ID: 28682525
    [No Abstract]   [Full Text] [Related]  

  • 4. Exanthematous Rash With Lurasidone in an Elderly Woman With Schizoaffective Disorder.
    Hafeez ZH
    Prim Care Companion CNS Disord; 2019 Mar; 21(2):. PubMed ID: 30947406
    [No Abstract]   [Full Text] [Related]  

  • 5. A Medication for Depression With Mixed Features.
    Coryell W
    Am J Psychiatry; 2016 Apr; 173(4):315-6. PubMed ID: 27035528
    [No Abstract]   [Full Text] [Related]  

  • 6. Lurasidone for schizophrenia.
    Drug Ther Bull; 2015 Mar; 53(3):30-2. PubMed ID: 25765597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziprasidone-related tardive dyskinesia.
    Keck ME; Müller MB; Binder EB; Sonntag A; Holsboer F
    Am J Psychiatry; 2004 Jan; 161(1):175-6. PubMed ID: 14702272
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient improvement of tardive dyskinesia induced with rTMS.
    Brambilla P; Perez J; Monchieri S; Rossini PM; Bonato C
    Neurology; 2003 Oct; 61(8):1155. PubMed ID: 14581693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term efficacy and safety of lurasidone in the treatment of schizophrenia].
    Samalin L; Honciuc M; Llorca PM
    Encephale; 2015 Dec; 41(6):541-9. PubMed ID: 26603973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of lurasidone for bipolar depression.
    Loebel A; Xu J; Hsu J; Cucchiaro J; Pikalov A
    Ann N Y Acad Sci; 2015 Nov; 1358():95-104. PubMed ID: 26771990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study.
    Suppes T; Silva R; Cucchiaro J; Mao Y; Targum S; Streicher C; Pikalov A; Loebel A
    Am J Psychiatry; 2016 Apr; 173(4):400-7. PubMed ID: 26552942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lurasidone-induced anemia: Is there a need for hematological monitoring?
    Kirpekar VC; Faye AD; Bhave SH; Tadke R; Gawande S
    Indian J Pharmacol; 2019; 51(4):276-278. PubMed ID: 31571715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lurasidone-Associated Manic Switch in a Patient With Depression: A Case Report.
    Gupta P; Singh J; Kumar N
    J Clin Psychopharmacol; 2019; 39(6):687-689. PubMed ID: 31688393
    [No Abstract]   [Full Text] [Related]  

  • 14. A Case of Emergent Restless Legs Syndrome With Lurasidone Therapy.
    Ghori AK; Sajatovic M; Tampi RR
    J Clin Psychopharmacol; 2016 Jun; 36(3):293-4. PubMed ID: 27035496
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute Onset of Abdominal Muscle Dyskinesia ('Belly Dancer Syndrome') From Quetiapine Exposure: A Case Report.
    Yeh JY; Tu KY; Tseng PT; Lee Y; Lin PY
    Clin Neuropharmacol; 2018; 41(2):73-74. PubMed ID: 29474193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression.
    Modugula H; Kumar A
    CNS Neurol Disord Drug Targets; 2020; 19(2):109-114. PubMed ID: 32124704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study.
    Tsai J; Thase ME; Mao Y; Ng-Mak D; Pikalov A; Loebel A
    CNS Spectr; 2017 Apr; 22(2):236-245. PubMed ID: 28357969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial.
    Sramek J; Loebel A; Murphy M; Mao Y; Pikalov A; Cutler NR
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():12-17. PubMed ID: 28499900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lurasidone-Associated Neuroleptic Malignant Syndrome.
    Lee M; Marshall D; Saddichha S
    J Clin Psychopharmacol; 2017 Oct; 37(5):639-640. PubMed ID: 28806387
    [No Abstract]   [Full Text] [Related]  

  • 20. Case Series Reports on Lurasidone-Associated Mania.
    Doan LA; Williams SR; Takayesu A; Lu B
    J Clin Psychopharmacol; 2017 Apr; 37(2):264-266. PubMed ID: 28225748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.